# Relative Bioavailability of a BI 187004 Tablet Formulation in Comparison With an Oral Solution and the Influence of Food on the Tablet Formulation in Healthy Volunteers

> **NCT02161432** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 17 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BI 187004
- **DRUG:** BI 187004
- **DRUG:** BI 187004

## Key facts

- **NCT ID:** NCT02161432
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2016-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02161432

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02161432, "Relative Bioavailability of a BI 187004 Tablet Formulation in Comparison With an Oral Solution and the Influence of Food on the Tablet Formulation in Healthy Volunteers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02161432. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*